Google Translate Disclaimer

A number of pages on the Government of Saskatchewan's website have been professionally translated in French. These translations are identified by a yellow box in the right or left rail that resembles the link below. The home page for French-language content on this site can be found at:

Renseignements en Français

Where an official translation is not available, Google™ Translate can be used. Google™ Translate is a free online language translation service that can translate text and web pages into different languages. Translations are made available to increase access to Government of Saskatchewan content for populations whose first language is not English.

Software-based translations do not approach the fluency of a native speaker or possess the skill of a professional translator. The translation should not be considered exact, and may include incorrect or offensive language. The Government of Saskatchewan does not warrant the accuracy, reliability or timeliness of any information translated by this system. Some files or items cannot be translated, including graphs, photos and other file formats such as portable document formats (PDFs).

Any person or entities that rely on information obtained from the system does so at his or her own risk. Government of Saskatchewan is not responsible for any damage or issues that may possibly result from using translated website content. If you have any questions about Google™ Translate, please visit: Google™ Translate FAQs.

Province Announces $15 Million in Funding for VIDO-InterVac Pandemic Research

Released on February 23, 2021

$15 million to support world-leading research in Saskatchewan

The Government of Saskatchewan is committing $15 million of new funding to further support important pandemic research by the Vaccine and Infectious Disease Organization (VIDO) at the University of Saskatchewan.

“COVID-19 has demonstrated the importance of Canada being a leader in research, development and production of new vaccines,” Premier Scott Moe said.  “The place that should happen is right here in Saskatchewan, at VIDO-InterVac in Saskatoon.  VIDO has made world-first breakthroughs and achieved significant momentum in vaccine and disease research, most recently with COVID-19 vaccine development, and this new facility will strengthen their position as Canada’s Centre for Pandemic Research.”

“This support from the Government of Saskatchewan is critical in strengthening VIDO’s position as a National Centre focused on pandemic research and preparedness,” VIDO Director Dr. Volker Gerdts said.  “The investment will help ensure the necessary infrastructure is in place to protect Canadians from future emerging infectious diseases.”

The $15 million provincial funding commitment is contingent on the Government of Canada committing and flowing funds to the project, which has already received committed funding committed by the City of Saskatoon and significant contributions from several private donors.  The province has formally written to the federal government to support VIDO-InterVac’s request for $45 million in federal government support and ongoing operating funding for this project.

The provincial commitment will support VIDO’s Centre for Pandemic Research, which will include an upgrade to Level 4 containment facilities.  Containment Level 4 laboratories provide the capability to work safely with the most serious and deadly human and animal diseases. Currently the only level 4 facility in Canada is the National Microbiology Lab in Winnipeg.

VIDO was originally designed and built to accommodate the possible future enhancement to Level 4 containment capability.  This includes 2000 square feet of existing lab space that can be readily upgraded to meet Level 4 containment requirements.

The Centre will also provide critical animal housing for multiple species and significantly reduce the time required to advance vaccine development to human clinical trials.  In addition, this Centre for Pandemic Research gives VIDO the capacity to develop the workforce and train the talent needed for a resilient vaccine and therapeutic ecosystem in Canada.

Since the COVID-19 pandemic began, the Government of Saskatchewan has provided VIDO-InterVac with additional funding of $4.2 million to support the development of a COVID-19 vaccine and construct a new small-scale manufacturing facility to be completed later this year.  This funding is in addition to annual operations funding of $3.8 million in 2019-20 and $4.1 million in 2020-21.


For more information, contact:

Julie Leggott
Executive Council
Phone: 306-787-9619

We need your feedback to improve Help us improve